GENEVA — A Covid-19 vaccine effective against multiple variants is possible before the end of 2022, the head of US pharmaceutical giant Pfizer said Wednesday. ADVERTISEMENT“I hope, clearly by autumn… that we could have a vaccine” that worked against not only the dominant Omicron but all known variants, he said. The IFPMA briefing condemned suggestions that intellectual property rights on Covid-19 vaccines should be temporarily lifted during the pandemic, in a bid to increase production. With more than a billion vaccine doses being produced every month, Eli Lilly chairman David Ricks called it “a solution looking for a problem”, while Bourla branded the idea “insane”. RELATED STORIESPH gets more than 1 million doses of Pfizer COVID-19 vaccinePfizer/BioNTech vaccine neutralizes Omicron virus variant with three shotsPfizer and BioNTech launch trial of Omicron-targeted COVID vaccineStudy suggests Pfizer COVID-19 vaccine only partially protects vs OmicronSubscribe to our daily newsletter By providing an email address.

Source: Philippine Daily Inquirer April 14, 2022 06:31 UTC